Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Mucosal Immunol ; 11(2): 345-356, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-28612843

RESUMO

In the two inflammatory bowel diseases, ulcerative colitis (UC) and Crohn's disease (CD), altered expression of tight junction (TJ) proteins leads to an impaired epithelial barrier including increased uptake of luminal antigens supporting the inflammation. Here, we focused on regulation of tricellulin (Tric), a protein of the tricellular TJ essential for the barrier against macromolecules, and hypothesized a role in paracellular antigen uptake. We report that Tric is downregulated in UC, but not in CD, and that its reduction increases the passage of macromolecules. Using a novel visualization method, passage sites were identified at TJ regions usually sealed by Tric. We show that interleukin-13 (IL-13), beyond its known effect on claudin-2, downregulates Tric expression. These two effects of IL-13 are regulated by different signaling pathways: The IL-13 receptor α1 upregulates claudin-2, whereas IL-13 receptor α2 downregulates Tric. We suggest to target the α2 receptor in future developments of therapeutical IL-13-based biologicals.


Assuntos
Colite Ulcerativa/imunologia , Inflamação/imunologia , Subunidade alfa2 de Receptor de Interleucina-13/metabolismo , Mucosa Intestinal/fisiologia , Proteína 2 com Domínio MARVEL/metabolismo , Junções Íntimas/metabolismo , Adulto , Idoso , Antígenos/imunologia , Antígenos/metabolismo , Claudina-2/metabolismo , Doença de Crohn/imunologia , Regulação para Baixo , Feminino , Células HT29 , Humanos , Interleucina-13/metabolismo , Subunidade alfa1 de Receptor de Interleucina-13/metabolismo , Substâncias Macromoleculares/imunologia , Substâncias Macromoleculares/metabolismo , Masculino , Pessoa de Meia-Idade , Terapia de Alvo Molecular , Transdução de Sinais , Adulto Jovem
3.
Mucosal Immunol ; 11(2): 474-485, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-28766554

RESUMO

Campylobacter jejuni is the most prevalent cause of foodborne bacterial enteritis worldwide. Patients present with diarrhea and immune responses lead to complications like arthritis and irritable bowel syndrome. Although studies exist in animal and cell models, we aimed at a functional and structural characterization of intestinal dysfunction and the involved regulatory mechanisms in human colon. First, in patients' colonic biopsies, sodium malabsorption was identified as an important diarrheal mechanism resulting from hampered epithelial ion transport via impaired epithelial sodium channel (ENaC) ß- and γ-subunit. In addition, barrier dysfunction from disrupted epithelial tight junction proteins (claudin-1, -3, -4, -5, and -8), epithelial apoptosis, and appearance of lesions was detected, which cause leak-flux diarrhea and can perpetuate immune responses. Importantly, these effects in human biopsies either represent direct action of Campylobacter jejuni (ENaC impairment) or are caused by proinflammatory signaling (barrier dysfunction). This was revealed by regulator analysis from RNA-sequencing (cytometric bead array-checked) and confirmed in cell models, which identified interferon-γ, TNFα, IL-13, and IL-1ß. Finally, bioinformatics' predictions yielded additional information on protective influences like vitamin D, which was confirmed in cell models. Thus, these are candidates for intervention strategies against C. jejuni infection and post-infectious sequelae, which result from the permissive barrier defect along the leaky gut.


Assuntos
Infecções por Campylobacter/imunologia , Campylobacter jejuni/fisiologia , Colo/imunologia , Enterite/imunologia , Mucosa Intestinal/metabolismo , Síndromes de Malabsorção/imunologia , Sódio/metabolismo , Adulto , Apoptose , Células Cultivadas , Colo/microbiologia , Biologia Computacional , Citocinas/genética , Citocinas/metabolismo , Enterite/microbiologia , Canais Epiteliais de Sódio/metabolismo , Feminino , Humanos , Mediadores da Inflamação/metabolismo , Mucosa Intestinal/patologia , Transporte de Íons , Síndromes de Malabsorção/microbiologia , Masculino , Pessoa de Meia-Idade , Transdução de Sinais , Proteínas de Junções Íntimas/metabolismo , Vitamina D/metabolismo
4.
Mucosal Immunol ; 10(6): 1542-1552, 2017 11.
Artigo em Inglês | MEDLINE | ID: mdl-28176790

RESUMO

Classical Whipple's disease (CWD) affects the gastrointestinal tract and rather elicits regulatory than inflammatory immune reactions. Mechanisms of malabsorption, diarrhea, and systemic immune activation are unknown. We here analyzed mucosal architecture, barrier function, and immune activation as potential diarrheal trigger in specimens from 52 CWD patients. Our data demonstrate villus atrophy and crypt hyperplasia associated with epithelial apoptosis and reduced alkaline phosphatase expression in the duodenum of CWD patients. Electrophysiological and flux experiments revealed increased duodenal permeability to small solutes and macromolecules. Duodenal architecture and permeability ameliorated upon antibiotic treatment. Structural correlates for these alterations were concordant changes of membranous claudin-1, claudin-2, claudin-3, and tricellulin expression. Tumor necrosis factor-α and interleukin-13 were identified as probable mediators of epithelial apoptosis, and altered tight junction expression. Increased serum markers of microbial translocation and their decline following treatment corroborated the biological significance of the mucosal barrier defect. Hence, mucosal immune responses in CWD elicit barrier dysfunction. Diarrhea is caused by loss of absorptive capacity and leak flux of ions and water. Downregulation of tricellulin causes increased permeability to macromolecules and subsequent microbial translocation contributes to systemic inflammation. Thus, therapeutic strategies to reconstitute the mucosal barrier and control inflammation could assist symptomatic control of CWD.


Assuntos
Duodeno/patologia , Mucosa Intestinal/imunologia , Intestino Delgado/patologia , Doença de Whipple/imunologia , Adulto , Idoso , Apoptose , Atrofia , Claudinas/metabolismo , Feminino , Humanos , Hiperplasia , Imunidade nas Mucosas , Interleucina-13/metabolismo , Proteína 2 com Domínio MARVEL/metabolismo , Masculino , Pessoa de Meia-Idade , Junções Íntimas , Fator de Necrose Tumoral alfa/metabolismo , Adulto Jovem
5.
Acta Physiol (Oxf) ; 219(2): 521-536, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-27359349

RESUMO

AIM: Claudin-2 is a tight junction protein typically located in 'leaky' epithelia exhibiting large paracellular permeabilities like small intestine and proximal kidney tubule. Former studies revealed that claudin-2 forms paracellular channels for small cations like sodium and potassium and also paracellular channels for water. This study analyses whether the diffusive transport of sodium and water occurs through a common pore of the claudin-2 channel. METHODS: Wild-type claudin-2 and different claudin-2 mutants were expressed in MDCK I kidney tubule cells using an inducible system. Ion and water permeability and the effect of blocking reagents on both were investigated on different clones of the mutants. RESULTS: Neutralization of a negatively charged cation interaction site in the pore with the mutation, D65N, decreased both sodium permeability and water permeability. Claudin-2 mutants (I66C and S68C) with substitution of the pore-lining amino acids with cysteine were used to test the effect of steric blocking of the claudin-2 pore by thiol-reactive reagents. Addition of thiol-reactive reagents to these mutants simultaneously decreased conductance and water permeability. Remarkably, all experimental perturbations caused parallel changes in ion conductance and water permeability, disproving different or independent passage pathways. CONCLUSION: Our results indicate that claudin-2-mediated cation and water transport are frictionally coupled and share a common pore. This pore is lined and determined in permeability by amino acid residues of the first extracellular loop of claudin-2.


Assuntos
Transporte Biológico/fisiologia , Claudina-2/metabolismo , Junções Íntimas/metabolismo , Animais , Western Blotting , Cátions/metabolismo , Cães , Imunofluorescência , Técnica de Fratura por Congelamento , Células Madin Darby de Rim Canino , Permeabilidade
6.
Cell Tissue Res ; 336(1): 67-77, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19214581

RESUMO

Our aim has been to characterize the molecular mechanisms regulating the expression of the channel-forming tight-junctional protein claudin-2 in response to the pro-inflammatory cytokine tumor necrosis factor-alpha (TNFalpha), which is elevated, for example, in active Crohn's disease. TNFalpha caused an 89% decrease of the paracellular resistance in colonic HT-29/B6 cells, whereas transcellular resistance was unaltered. The claudin-2 protein level was increased by TNFalpha without changes in subcellular tight-junctional protein localization as revealed by confocal laser scanning microscopy. Enhanced gene expression was identified as the source of this increase, since claudin-2-specific mRNA and promoter activity was elevated, whereas mRNA stability remained unaltered. Specific inhibitors and phospho-specific antibodies revealed that the increased gene expression of claudin-2 after TNFalpha treatment was mediated by the phosphatidylinositol-3-kinase pathway. Thus, the up-regulation of claudin-2 by TNFalpha is attributable to the regulation of the expression of the gene, as a result of which epithelial barrier function is disturbed, for example, during chronic intestinal inflammation.


Assuntos
Proteínas de Membrana/genética , Fosfatidilinositol 3-Quinases/fisiologia , Fator de Necrose Tumoral alfa/farmacologia , Cromonas/farmacologia , Claudinas , Relação Dose-Resposta a Droga , Inibidores Enzimáticos/farmacologia , Células HT29 , Humanos , Mucosa Intestinal/metabolismo , Proteínas de Membrana/metabolismo , Morfolinas/farmacologia , Fosfatidilinositol 3-Quinases/metabolismo , Inibidores de Fosfoinositídeo-3 Quinase , Transdução de Sinais/efeitos dos fármacos , Junções Íntimas/genética , Junções Íntimas/metabolismo , Distribuição Tecidual , Regulação para Cima/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...